AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 151 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $149,000 | -26.2% | 13,132 | +4.2% | 0.00% | 0.0% |
| Q2 2021 | $202,000 | -6.9% | 12,598 | +4.0% | 0.00% | 0.0% |
| Q1 2021 | $217,000 | +48.6% | 12,116 | +12.2% | 0.00% | 0.0% |
| Q4 2020 | $146,000 | -41.6% | 10,799 | -49.2% | 0.00% | 0.0% |
| Q3 2020 | $250,000 | -15.3% | 21,258 | +6.6% | 0.00% | -50.0% |
| Q2 2020 | $295,000 | +47.5% | 19,949 | +34.2% | 0.00% | +100.0% |
| Q1 2020 | $200,000 | -14.2% | 14,864 | +54.4% | 0.00% | 0.0% |
| Q4 2019 | $233,000 | – | 9,629 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |